Endometrial Cancer
Conditions
Interventions
Gold Standard:1)Endometrial tissue pathological results obtained after curettage
2) Pathological results of endometrial tissue obtained after total hysterectomy.
cell 
results 
by 
Li-brush
Sponsors
First Affiliated Hospital, Xi'an Jiaotong University
Eligibility
Sex/Gender
Female
Age
25 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Group A: 1) Childbearing age, vaginal bleeding after the use of IUD, the amount is small, there are still contraceptive needs; 2) B-ultrasound suggests that the intima thickening is uneven or sputum, no abnormal bleeding, IUD patients who need to exclude endometrial lesions, such as long-term oral tamoxifen after breast cancer surgery; 3) Mirena treatment of endometrial atypical hyperplasia or endometrial hyperplasia, requiring regular review; 4) Place the IUD in the uterus and ask for screening for endometrial lesions. Group B: 1) Abnormal uterine bleeding requires IUD patients who have been diagnosed and stopped by surgery; 2) Postmenopausal vaginal bleeding requires removal of the ring and the diagnosis of IUD patients with lesions. 2. 1) Patients undergoing diagnostic curettage; 2) Patients undergoing total hysterectomy. 3. 1) Patients undergoing diagnostic curettage; 2) Patients undergoing total hysterectomy. 4. 1) Patients undergoing diagnostic curettage; 2) Patients undergoing total hysterectomy.
Exclusion criteria
Exclusion criteria: 1. 1) acute inflammation of the reproductive system (except atrophic vaginitis); 2) endogenous cervical cancer; 3) abnormal blood coagulation and other blood system diseases that affect blood coagulation; 4) Pregnancy or suspected pregnancy; 5) The amount of bleeding is large, and it is necessary to urgently cure and stop bleeding; 6) Highly suspected that the IUD is displaced, even causing uterus and cervical perforation; 7) Peri-menopause, it is recommended to take out the IUD. 8) Women of childbearing age who have a pregnancy request and request to take out the IUD; 9) Those who have a body temperature exceeding 37.5 °C on the day of the visit. 2. 1) Acute inflammation of the reproductive system (except atrophic vaginitis); 2) Endogenous cervical cancer; 3) Abnormal blood coagulation function and other blood system diseases that affect blood coagulation; 4) Those who have a large amount of bleeding and need urgent diagnosis and curettage; 5) Those whose body temperature exceeds 37.5? twice on the day of treatment. 3. 1) Acute inflammation of the reproductive system (except atrophic vaginitis); 2) Endogenous cervical cancer; 3) Abnormal blood coagulation function and other blood system diseases that affect blood coagulation; 4) Those who have a large amount of bleeding and need urgent diagnosis and curettage; 5) Those whose body temperature exceeds 37.5? twice on the day of treatment. 4. 1)Cervical cancer, ovarian cancer, peritoneal cancer; 2)acute severe systemic disease 3)acute inflammation of the reproductive system (except atrophic vaginitis); 4)abnormal blood coagulation function and other blood system diseases that affect blood coagulation; 5) Those who have a large amount of bleeding and need urgent diagnosis and curettage; 6) Those whose body temperature exceeds 37.5? twice on the day of treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the cytopathologic diagnosis ;IUD upper edge distance from the fundus serosa;the histopathologic diagnosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| the histopathologic diagnosis ; | — |
Countries
China
Contacts
Public ContactLu Han
First Affiliated Hospital, Xi'an Jiaotong University
Outcome results
None listed